ARDELYX, INC. Area of Real Estate Property
ARDELYX, INC. (ARDX) had Area of Real Estate Property of 10.72 thousand sqft as of 2020-12-31, per its 10-K filed 2021-03-08.
Discontinued › Notes › Consolidation and Presentation of Financial Statements
us-gaap:AreaOfRealEstateProperty · last filed 2021-03-08
- 2020-12-31: Area of Real Estate Property 10.72K sqft.
- 2020-10-31: Area of Real Estate Property 4.77K sqft.
- 2019-12-31: Area of Real Estate Property 10.72K sqft.
- 2019-09-30: Area of Real Estate Property 10.72K sqft.
| Period end | Area of Real Estate Property | Area of Real Estate Property as first filed |
|---|---|---|
| 2020-12-31 | 10.72K sqft 10-K · filed 2021-03-08 | |
| 2020-10-31 | 4.77K sqft 10-K · filed 2021-03-08 | |
| 2019-12-31 | 10.72K sqft 10-K · filed 2020-03-06 | |
| 2019-09-30 | 10.72K sqft 10-Q · filed 2019-11-06 | |
| 2018-10-31 | 3.52K sqft 10-K · filed 2021-03-08 | 3.25K sqft 10-Q · filed 2019-05-07 |
| 2016-04-30 | 72.50K sqft 10-K · filed 2021-03-08 | 61.78K sqft 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |